LPA and familial hyperaldosteronism: Two major studies showed that incorporating Lp(a) into the genetic cascade testing of FH in families of probands with FH mutations is an effective way of identifying hyper-Lp(a) in this high-risk group (Ellis et al., 2019; Chakraborty et al., 2021).